FMP
Reliance Steel & Aluminum Co.
RS
NYSE
Reliance Steel & Aluminum Co. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It also distributes non-ferrous metals products and tubular building products; and manufactures specialty extruded metals, fabricated parts, and welded components. As of December 31, 2021, the company operated a network of approximately 315 locations in 40 states in the United States and 13 in other countries. It sells its products directly to original equipment manufacturers, which primarily include small machine shops and fabricators. The company was founded in 1939 and is headquartered in Los Angeles, California.
288.23 USD
0.17 (0.05898%)
Historical Prices
From:
To:
About
Description
Reliance Steel & Aluminum Co. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It also distributes non-ferrous metals products and tubular building products; and manufactures specialty extruded metals, fabricated parts, and weld...
CIK
0000861884
ISIN
US7595091023
CUSIP
759509102
Address
350 South Grand Avenue
Phone
213 687 7700
Country
US
Employee
15,900
IPO Date
Sep 16, 1994
Financial Statement
Earnings
RS Financial Summary
CIK
0000861884
Exchange
NYSE
Industry
Steel
Sector
Basic Materials
CUSIP
759509102
ISIN
US7595091023
Country
US
Price
288.23
Beta
0.82
Volume Avg.
448.84k
Market Cap
15.24B
Shares
-
52-Week
250.07-326.87
DCF
673.1
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
20.5
P/B
-
Website
https://www.rsac.com
Upgrades and Downgrades
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RS News
Alex Lavoie
Apr 11, 2025
Northern Trust (NASDAQ:NTRS) Faces Downgrade Amid Evolving A...
Northern Trust (NASDAQ:NTRS) is a financial services company that provides asset management, asset servicing, and wealth management services. It operates globally, serving institutional and individual clients. The company faces competition from other financial giants like Morgan Stanley, which recently downgraded Northern Trust to an "Underweight" rating, as highlighted by TheFly. The peer study by Northern Trust sheds light on the changing priorities of global asset owners. As these financial ...
Rayan Ahmad
Mar 14, 2025
AirSculpt Technologies, Inc. (NASDAQ:AIRS) Faces Financial C...
AirSculpt Technologies, Inc. (NASDAQ:AIRS) is a prominent player in the body contouring industry, known for its innovative and minimally invasive procedures. The company operates 32 centers worldwide and has performed over 70,000 procedures. Despite its strong market presence, AIRS faces stiff competition from other cosmetic surgery providers. The company recently reported its financial results for the fourth quarter and full year ending December 31, 2024. On March 14, 2025, AIRS announced an e...
Andrew Wynn
Mar 2, 2025
Northern Trust Corporation's Financial Performance Compared ...
Northern Trust Corporation (NASDAQ:NTRS) is a financial services company that provides wealth management, asset servicing, asset management, and banking solutions. It competes with other financial institutions like State Street Corporation, Comerica Incorporated, M&T Bank Corporation, Zions Bancorporation, and Marsh & McLennan Companies. These companies are evaluated based on their Return on Invested Capital (ROIC) and Weighted Average Cost of Capital (WACC). Northern Trust's ROIC is 0.8158%, w...
Danny Green
Feb 24, 2025
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Overview: Key Ins...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is a clinical-stage biopharmaceutical company focused on developing treatments for eye conditions and other diseases. Their lead product, TP-03, is in Phase III trials for blepharitis caused by Demodex mites. Tarsus is also working on TP-04 for rosacea and TP-05 for Lyme disease and malaria prevention. The company competes with other biopharmaceutical firms in the ophthalmic and dermatological sectors. The consensus price target for Tarsus has fluctuat...
Gordon Thompson
Feb 19, 2025
CRISPR Therapeutics AG (NASDAQ:CRSP) Surpasses Earnings Esti...
CRISPR Therapeutics AG (NASDAQ:CRSP) is a leading biotechnology company focused on developing transformative gene-based medicines. The company is renowned for its pioneering work in CRISPR/Cas9 gene-editing technology, which aims to treat serious diseases. CRSP operates in the competitive Zacks Medical - Biomedical and Genetics industry, where it faces competition from other biotech firms like Editas Medicine and Intellia Therapeutics. On February 19, 2025, CRSP reported an earnings per share (...
Rayan Ahmad
Feb 18, 2025
CRISPR Therapeutics AG (NASDAQ:CRSP) Overview: A Leader in G...
CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneering gene editing company that develops gene-based medicines for serious diseases using its CRISPR/Cas9 platform. The company has a diverse portfolio targeting hemoglobinopathies, oncology, regenerative medicine, and rare diseases. Its lead product, CTX001, is an ex vivo CRISPR gene-edited therapy for beta-thalassemia and sickle cell disease. The consensus price target for CRSP's stock has seen a decline over the past year, dropping from $72.75 to...
Gordon Thompson
Feb 11, 2025
Jerash Holdings (JRSH) Earnings Report Highlights
Jerash Holdings (NASDAQ:JRSH) is a company that manufactures and exports custom sportswear and outerwear for major global brands. On February 11, 2025, JRSH reported its earnings before the market opened. The company had an earnings per share (EPS) of approximately -$0.00047, which was better than the estimated EPS of -$0.03. JRSH's actual revenue was approximately $35.38 million, slightly below the estimated revenue of $35.4 million. During the Q3 2025 earnings conference call, key company fig...
Alex Lavoie
Feb 7, 2025
VeriSign, Inc. (NASDAQ: VRSN) Earnings Report Highlights
VeriSign, Inc. (NASDAQ: VRSN) is a prominent player in the internet services sector, specializing in critical internet infrastructure and domain name registry services. The company is known for managing a significant portion of the world's domain names, which is a crucial aspect of the internet's backbone. VeriSign competes with other domain registry service providers, but it maintains a strong market position due to its extensive experience and reliable services. On February 6, 2025, VeriSign ...
